Update 2021 : COVID-19 from the Perspective of Haematology and Haemostaseology

Thieme. All rights reserved..

Infection with SARS-CoV-2 has a profound influence on the hematopoetic system that mediates clinical symptoms and mortality. Several studies have shown that treatment of the cytokine storm (CRS) with anti-inflammatory drugs like dexamethasone and tocilizumab can significantly improve survival. Systematic reviews confirm the safety of convalescent plasma administration and offer initial indications of its effectiveness in certain groups. COVID-associated coagulopathy (CAC) and vaccine-induced immune thrombotic thrombocytopenia (VITT) represent severe infection- or vaccination associated complications that require a specific diagnostic and therapeutic workup.

Media Type:

Electronic Article

Year of Publication:

2021

Contained In:

Deutsche medizinische Wochenschrift (1946) - Vol. 146, No. 13-14 (2021), p. 899-903

Language:

German

Other Title:

Update 2021: COVID-19 aus Sicht der Hämatologie und Hämostaseologie

Contributors:

Spiekermann, Karsten
Subklewe, Marion
Hildebrandt, Martin
Humpe, Andreas
von Bergwelt-Baildon, Michael

Links:

Volltext

Keywords:

*Hematology
*Hematopoiesis
*Hemostasis
Blood Coagulation Disorders
COVID-19
Humans
Immunization, Passive
Journal Article
Review
SARS-CoV-2

Notes:

Date Completed 20.07.2021

Date Revised 20.07.2021

published: Print-Electronic

Citation Status MEDLINE

Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Physical Description:

Online-Ressource

doi:

10.1055/a-1449-4934

PMID:

34256404

PPN (Catalogue-ID):

NLM329179330